Halaven 1 MG in 2 ML Injection
- RxCUI
- 1045460
- RxNorm name
- Halaven 1 MG in 2 ML Injection
- Display name
- Halaven 1 MG in 2 ML Injection
- Full name
- Halaven 1 MG in 2 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Halaven | ERIBULIN MESYLATE | BSP Pharmaceuticals SpA | 8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6 | 2026-01-26 | 1045460 | |
| Halaven | ERIBULIN MESYLATE | Eisai Inc. | 31ce4750-ded5-4a0b-95e9-f229fa6bc822 | 2025-11-07 | Warnings, Adverse reactions | 1045460 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 31ce4750-ded5-4a0b-95e9-f229fa6bc822 | Halaven 1 MG in 2 ML Injection [PSN] · 2 ML eribulin mesylate 0.5 MG/ML Injection [Halaven] [SBD] · 2 ML Halaven 0.5 MG/ML Injection [SY] · Halaven 1 MG per 2 ML Injection [SY] | 4 | 69 | These highlights do not include all the information needed to use HALAVEN safely and effectively. See full prescribing information for HALAVEN. HALAVEN ® (eribulin mesylate) injection, for intravenous use Initial U.S. Approval: 2010 | 20251107 |
| 8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6 | Halaven 1 MG in 2 ML Injection [PSN] · 2 ML eribulin mesylate 0.5 MG/ML Injection [Halaven] [SBD] · 2 ML Halaven 0.5 MG/ML Injection [SY] · Halaven 1 MG per 2 ML Injection [SY] | 4 | 58 | HALAVEN ® (eribulin mesylate) injection 0.5 mg/mL | 20260126 |